NRGN and Alzheimer disease: Ng has abundant neuronal expression in the central nervous system and compared with traditional biomarkers, Ng can detect the pathological changes of AD at an earlier stage, even in the MCI stage, so far it is considered to be a potential biomarker for diagnosis of AD16.